Stelara and Brilinta drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Stelara (ustekinumab) and Brilinta (ticagrelor). Common drug interactions include diarrhoea among females and angina pectoris among males.
The phase IV clinical study analyzes what interactions people have when they take Stelara and Brilinta. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.
What is Stelara?
Stelara has active ingredients of ustekinumab. It is often used in psoriasis. eHealthMe is studying from 96,053 Stelara users. Check the latest studies of Stelara.
What is Brilinta?
Brilinta has active ingredients of ticagrelor. It is often used in stent. eHealthMe is studying from 22,469 Brilinta users. Check the latest studies of Brilinta.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
18 people who take Stelara and Brilinta together, and have interactions are studied.

What are the common drug interactions of Stelara and Brilinta, by gender? *:
female:
- Diarrhoea
- Urticaria (rash of round, red welts on the skin that itch intensely)
- Dyspnoea (difficult or laboured respiration)
- Abdominal pain upper
- Drug hypersensitivity
- Headache (pain in head)
- Angioplasty
- Hypersensitivity
- Bedridden
- Fatigue (feeling of tiredness)
male:
- Angina pectoris (chest pain due to ischemia of the heart muscle)
- Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
- Skin haemorrhage (bleeding into skin)
- Pain of skin
- Umbilical hernia (an outward bulging (protrusion) of the abdominal lining or part of the abdominal organ(s) through the area around the belly button)
- Arthritis (form of joint disorder that involves inflammation of one or more joints)
- Chest pain
- Osteoarthritis (a joint disease caused by cartilage loss in a joint)
- Drug effect decreased
- Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
What are the common drug interactions of Stelara and Brilinta, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Diarrhoea
- Urticaria (rash of round, red welts on the skin that itch intensely)
- Abdominal pain upper
- Drug hypersensitivity
- Headache (pain in head)
40-49:
n/a
50-59:
- Drug effect decreased
60+:
- Angina pectoris (chest pain due to ischemia of the heart muscle)
- Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
- Skin haemorrhage (bleeding into skin)
- Pain of skin
- Umbilical hernia (an outward bulging (protrusion) of the abdominal lining or part of the abdominal organ(s) through the area around the belly button)
- Arthritis (form of joint disorder that involves inflammation of one or more joints)
- Chest pain
- Osteoarthritis (a joint disease caused by cartilage loss in a joint)
- Bedridden
- Fatigue (feeling of tiredness)
What are the existing conditions these people have? *
- Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 5 people, 27.78%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 11.11%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.56%
- Pain: 1 person, 5.56%
- Muscle Spasms (muscle contraction): 1 person, 5.56%
- Joint Pain: 1 person, 5.56%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 5.56%
- Cardiac Disorder: 1 person, 5.56%
* Approximation only. Some reports may have incomplete information.
Do you take Stelara and Brilinta?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Stelara and Brilinta:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Stelara:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Brilinta:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Stelara and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Brilinta and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on ustekinumab and ticagrelor (the active ingredients of Stelara and Brilinta, respectively), and Stelara and Brilinta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Atropine cause Angioedema? - now
- Multiple Sclerosis and Vomiting Aggravated - 7 seconds ago
- Drug interactions of Aripiprazole and Saphris - 7 seconds ago
- Orkambi and Stomachache for Girls aged 10-19 - 11 seconds ago
- Orkambi and Stomach Pain for Girls aged 10-19 - 11 seconds ago
- Orkambi and Pain - Abdomen for Girls aged 10-19 - 11 seconds ago
- Orkambi and Belly Ache for Girls aged 10-19 - 11 seconds ago
- Orkambi and Abdominal Cramps for Girls aged 10-19 - 12 seconds ago
- Orkambi and Abdominal Pain for Girls aged 10-19 - 12 seconds ago
- Oxazepam and Tylenol drug interactions for men aged 60+ - 15 seconds ago